共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R022977-5mg | 5mg | 5~7个工作日 |
N-[3-(2,1,3-苯并噻二唑-5-氨基)-2-喹喔... SAR245408 |
99% |
|
|
阿拉丁 | X129499-10mg | 10mg | 现货 |
XL147,PI3K抑制剂 XL147 |
Moligand™, ≥98% |
|
|
阿拉丁 | X129499-50mg | 50mg | 现货 |
XL147,PI3K抑制剂 XL147 |
Moligand™, ≥98% |
|
|
阿拉丁 | X129499-100mg | 100mg | 现货 |
XL147,PI3K抑制剂 XL147 |
Moligand™, ≥98% |
|
|
阿拉丁 | X129499-25mg | 25mg | 现货 |
XL147,PI3K抑制剂 XL147 |
Moligand™, ≥98% |
|
|
阿拉丁 | X427110-1ml | 1ml | 现货 |
XL147 XL147 |
Moligand™, 2mM in DMSO |
|
|
毕得 | BD208927-100mg | 100mg | 现货 |
N-[3-(苯并[c][1,2,5]噻二唑-5-基氨基)... N-(3-(Benzo[c][1,2,5]thiadia... |
98+% |
|
|
毕得 | BD208927-25mg | 25mg | 现货 |
N-[3-(苯并[c][1,2,5]噻二唑-5-基氨基)... N-(3-(Benzo[c][1,2,5]thiadia... |
98+% |
|
|
毕得 | BD208927-250mg | 250mg | 现货 |
N-[3-(苯并[c][1,2,5]噻二唑-5-基氨基)... N-(3-(Benzo[c][1,2,5]thiadia... |
98+% |
|
|
Matrix | MA145095-50mg | 50mg | 3-4周 |
N-[3-(2,1,3-Benzothiadiazol-... N-[3-(2,1,3-Benzothiadiazol-... |
95% | 咨询 | 请联系客服购买! |
Matrix | MA145095-100mg | 100mg | 3-4周 |
N-[3-(2,1,3-Benzothiadiazol-... N-[3-(2,1,3-Benzothiadiazol-... |
95% | 咨询 | 请联系客服购买! |
源叶 | S81163-5mg | 5mg | 现货 |
XL147 XL147 |
96% |
|
|
源叶 | S81163-10mg | 10mg | 现货 |
XL147 XL147 |
96% |
|
|
源叶 | S81163-50mg | 50mg | 现货 |
XL147 XL147 |
96% |
|
|
源叶 | S81163-100mg | 100mg | 期货,请咨询 |
XL147 XL147 |
96% |
|
|
源叶 | S81163-200mg | 200mg | 期货,请咨询 |
XL147 XL147 |
96% |
|
|
源叶 | T88610-1ml | 1ml | 期货,请咨询 |
XL147 XL147 |
2mM in DMSO |
|
|
Target Mol | T2377-1mg | 1mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-2mg | 2mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-5mg | 5mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-10mg | 10mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-50mg | 50mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-100mg | 100mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-200mg | 200mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-1mL | 1mL | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Target Mol | T2377-25mg | 25mg | 现货 |
化合物 XL147 analogue Pilaralisib analogue |
99.72% |
|
|
Am | A978997-50mg | 50mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
98+% |
|
|
Am | A978997-100mg | 100mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
98+% |
|
|
Am | A978997-10mg | 10mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
98+% |
|
|
Am | A978997-25mg | 25mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
98+% |
|
|
Am | A978997-5mg | 5mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
98+% |
|
|
Am | A978997-1mg | 1mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
98+% |
|
|
MCE | HY-11105-100mg | 100mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
99.67% |
|
|
MCE | HY-11105-50mg | 50mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
99.67% |
|
|
MCE | HY-11105-10mM*1mL | 10mM*1mL | 现货 |
Pilaralisib analogue Pilaralisib analogue |
99.67% |
|
|
MCE | HY-11105-10mg | 10mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
99.67% |
|
|
MCE | HY-11105-5mg | 5mg | 现货 |
Pilaralisib analogue Pilaralisib analogue |
99.67% |
|
|